vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and Repay Holdings Corp (RPAY). Click either name above to swap in a different company.
Repay Holdings Corp is the larger business by last-quarter revenue ($78.6M vs $47.7M, roughly 1.6× IRONWOOD PHARMACEUTICALS INC). IRONWOOD PHARMACEUTICALS INC runs the higher net margin — -4.8% vs -178.3%, a 173.5% gap on every dollar of revenue. On growth, Repay Holdings Corp posted the faster year-over-year revenue change (0.4% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $23.2M). Over the past eight quarters, Repay Holdings Corp's revenue compounded faster (-1.3% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
Repay Holdings Corp is a leading payment technology provider delivering integrated end-to-end payment processing solutions for businesses across North America. Its offerings include credit/debit card processing, ACH transfer services, POS system integrations and digital payment tools, serving retail, healthcare, automotive and e-commerce segments to help clients streamline transaction workflows and boost operational efficiency.
IRWD vs RPAY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $78.6M |
| Net Profit | $-2.3M | $-140.1M |
| Gross Margin | — | 74.2% |
| Operating Margin | 14.3% | -182.2% |
| Net Margin | -4.8% | -178.3% |
| Revenue YoY | -47.3% | 0.4% |
| Net Profit YoY | -200.9% | -3304.1% |
| EPS (diluted) | $0.01 | $-1.68 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.7M | $78.6M | ||
| Q3 25 | $122.1M | $77.7M | ||
| Q2 25 | $85.2M | $75.6M | ||
| Q1 25 | $41.1M | $77.3M | ||
| Q4 24 | $90.5M | $78.3M | ||
| Q3 24 | $91.6M | $79.1M | ||
| Q2 24 | $94.4M | $74.9M | ||
| Q1 24 | $74.9M | $80.7M |
| Q4 25 | $-2.3M | $-140.1M | ||
| Q3 25 | $40.1M | $-6.4M | ||
| Q2 25 | $23.6M | $-102.3M | ||
| Q1 25 | $-37.4M | $-7.9M | ||
| Q4 24 | $2.3M | $-4.1M | ||
| Q3 24 | $3.6M | $3.2M | ||
| Q2 24 | $-860.0K | $-4.1M | ||
| Q1 24 | $-4.2M | $-5.2M |
| Q4 25 | — | 74.2% | ||
| Q3 25 | — | 74.4% | ||
| Q2 25 | — | 75.7% | ||
| Q1 25 | — | 75.9% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | — | 77.8% | ||
| Q2 24 | — | 78.2% | ||
| Q1 24 | — | 76.2% |
| Q4 25 | 14.3% | -182.2% | ||
| Q3 25 | 61.8% | -3.9% | ||
| Q2 25 | 53.2% | -138.7% | ||
| Q1 25 | -70.7% | -4.7% | ||
| Q4 24 | 34.8% | -1.5% | ||
| Q3 24 | 28.0% | -0.9% | ||
| Q2 24 | 26.5% | -4.6% | ||
| Q1 24 | 14.7% | -3.1% |
| Q4 25 | -4.8% | -178.3% | ||
| Q3 25 | 32.8% | -8.3% | ||
| Q2 25 | 27.7% | -135.2% | ||
| Q1 25 | -90.9% | -10.3% | ||
| Q4 24 | 2.5% | -5.3% | ||
| Q3 24 | 4.0% | 4.1% | ||
| Q2 24 | -0.9% | -5.4% | ||
| Q1 24 | -5.6% | -6.5% |
| Q4 25 | $0.01 | $-1.68 | ||
| Q3 25 | $0.23 | $-0.08 | ||
| Q2 25 | $0.14 | $-1.15 | ||
| Q1 25 | $-0.23 | $-0.09 | ||
| Q4 24 | $0.03 | $-0.04 | ||
| Q3 24 | $0.02 | $0.03 | ||
| Q2 24 | $-0.01 | $-0.04 | ||
| Q1 24 | $-0.03 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | $115.7M |
| Total DebtLower is stronger | — | $280.1M |
| Stockholders' EquityBook value | $-261.8M | $484.4M |
| Total Assets | $396.9M | $1.2B |
| Debt / EquityLower = less leverage | — | 0.58× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $215.5M | $115.7M | ||
| Q3 25 | $140.4M | $95.7M | ||
| Q2 25 | $92.9M | $162.6M | ||
| Q1 25 | $108.5M | $165.5M | ||
| Q4 24 | $88.6M | $189.5M | ||
| Q3 24 | $88.2M | $168.7M | ||
| Q2 24 | $105.5M | $147.1M | ||
| Q1 24 | $121.5M | $128.3M |
| Q4 25 | — | $280.1M | ||
| Q3 25 | $199.5M | $279.5M | ||
| Q2 25 | $199.3M | $279.0M | ||
| Q1 25 | $199.2M | $497.6M | ||
| Q4 24 | $199.0M | $496.8M | ||
| Q3 24 | $198.8M | $496.2M | ||
| Q2 24 | $198.6M | $435.6M | ||
| Q1 24 | $398.3M | $434.9M |
| Q4 25 | $-261.8M | $484.4M | ||
| Q3 25 | $-264.2M | $616.9M | ||
| Q2 25 | $-308.2M | $633.7M | ||
| Q1 25 | $-334.1M | $755.7M | ||
| Q4 24 | $-301.3M | $761.3M | ||
| Q3 24 | $-311.3M | $754.7M | ||
| Q2 24 | $-321.7M | $815.4M | ||
| Q1 24 | $-330.5M | $813.8M |
| Q4 25 | $396.9M | $1.2B | ||
| Q3 25 | $396.1M | $1.3B | ||
| Q2 25 | $342.9M | $1.4B | ||
| Q1 25 | $327.2M | $1.5B | ||
| Q4 24 | $350.9M | $1.6B | ||
| Q3 24 | $389.5M | $1.6B | ||
| Q2 24 | $395.6M | $1.5B | ||
| Q1 24 | $438.8M | $1.5B |
| Q4 25 | — | 0.58× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.44× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.65× | ||
| Q3 24 | — | 0.66× | ||
| Q2 24 | — | 0.53× | ||
| Q1 24 | — | 0.53× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | $23.3M |
| Free Cash FlowOCF − Capex | $74.6M | $23.2M |
| FCF MarginFCF / Revenue | 156.3% | 29.6% |
| Capex IntensityCapex / Revenue | 0.0% | 0.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | $90.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $23.3M | ||
| Q3 25 | $47.6M | $32.2M | ||
| Q2 25 | $-15.1M | $33.1M | ||
| Q1 25 | $20.0M | $2.5M | ||
| Q4 24 | $15.2M | $34.3M | ||
| Q3 24 | $9.9M | $60.1M | ||
| Q2 24 | $33.5M | $31.0M | ||
| Q1 24 | $45.0M | $24.8M |
| Q4 25 | $74.6M | $23.2M | ||
| Q3 25 | $47.6M | $32.1M | ||
| Q2 25 | $-15.1M | $33.0M | ||
| Q1 25 | $19.9M | $2.4M | ||
| Q4 24 | — | $34.0M | ||
| Q3 24 | $9.9M | $59.8M | ||
| Q2 24 | $33.4M | $30.5M | ||
| Q1 24 | $44.9M | $24.7M |
| Q4 25 | 156.3% | 29.6% | ||
| Q3 25 | 39.0% | 41.3% | ||
| Q2 25 | -17.7% | 43.6% | ||
| Q1 25 | 48.4% | 3.0% | ||
| Q4 24 | — | 43.5% | ||
| Q3 24 | 10.8% | 75.6% | ||
| Q2 24 | 35.4% | 40.7% | ||
| Q1 24 | 60.0% | 30.6% |
| Q4 25 | 0.0% | 0.1% | ||
| Q3 25 | 0.0% | 0.2% | ||
| Q2 25 | 0.0% | 0.1% | ||
| Q1 25 | 0.1% | 0.2% | ||
| Q4 24 | 0.0% | 0.3% | ||
| Q3 24 | 0.0% | 0.3% | ||
| Q2 24 | 0.1% | 0.6% | ||
| Q1 24 | 0.1% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | 1.19× | — | ||
| Q2 25 | -0.64× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 6.74× | — | ||
| Q3 24 | 2.71× | 18.52× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRWD
Segment breakdown not available.
RPAY
| Sales Channel Directly To Consumer | $69.4M | 88% |
| Other | $6.8M | 9% |
| Sales Channel Through Intermediary | $2.3M | 3% |
